Ranexa

Product NDC: 61958-1003
11-digit product format: 619581003
Labeler code: 61958
Product ID: 61958-1003_ba1f4469-5e3c-447a-9d28-8e57a2c32a17
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: RANOLAZINE
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Gilead Sciences, Inc.
Application: NDA021526
Marketing category: NDA
Marketing start: 2006-01-27
Marketing end: 0000-00-00
Substance: RANOLAZINE
Active strength: 500 mg/1
Pharmacologic classes: Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	61958-1003		D	Discontinued by firm	2026-08-11
excluded package	package	61958-1003	61958-1003-1	D	Discontinued by firm	2026-08-11
excluded package	package	61958-1003	61958-1003-2	D	Discontinued by firm	2026-08-11
excluded package	package	61958-1003	61958-1003-3	D	Discontinued by firm	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61958-1003-2	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61958-1003-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61958-1003-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61958-1003-2	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61958-1003-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61958-1003-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61958-1003-2	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61958-1003-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61958-1003-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61958-1003-2	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61958-1003-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61958-1003-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61958-1003-2	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61958-1003-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61958-1003-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61958-1003-2	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61958-1003-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61958-1003-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61958-1003-2	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61958-1003-3	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61958-1003-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61958-1003-2	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61958-1003-3	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61958-1003-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61958-1003-2	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61958-1003-3	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61958-1003-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61958-1003-2	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61958-1003-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61958-1003-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61958-1003-2	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61958-1003-3	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61958-1003-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61958-1003-2	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61958-1003-3	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61958-1003-1	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021526-001	RANEXA	RANOLAZINE	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12
N021526-002	RANEXA	RANOLAZINE	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021526-001	RANEXA	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2007-02-12	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021526-002	RANEXA	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD	2006-01-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021526-001	RANEXA	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2007-02-12	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021526-002	RANEXA	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2006-01-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021526-001	RANEXA	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2007-02-12	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021526-002	RANEXA	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2006-01-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021526-001	RANEXA	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2007-02-12	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021526-002	RANEXA	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2006-01-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021526-001	RANEXA	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2007-02-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	RANEXA	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2006-01-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021526-001	RANEXA	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2007-02-12	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021526-002	RANEXA	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2006-01-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021526-001	RANEXA	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2007-02-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021526-002	RANEXA	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2006-01-27	`782e0a99824c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021526-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021526-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021526-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021526-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021526-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021526-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021526-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021526-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021526-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021526-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021526-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021526-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021526-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021526-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021526-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021526-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021526-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021526-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021526-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021526-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021526-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021526-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021526-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021526-002	AB	1	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	N021526-001	AB	1	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N021526-002	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021526-001	AB	1	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021526-002	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021526-001	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N021526-002	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021526-001	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N021526-002	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021526-001	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021526-002	AB	1	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 80 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021526-001	6303607	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6369062	2019-05-27		Drug product, Delist requested	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6479496	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6503911	2019-05-27		Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6525057	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6562826	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6617328	2019-05-27		Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6620814	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6852724	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-001	6864258	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6303607	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6369062	2019-05-27		Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6479496	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6503911	2019-05-27		Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6525057	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6562826	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6617328	2019-05-27		Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6620814	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6852724	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021526-002	6864258	2019-05-27	U-705		`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6303607	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6369062	2019-05-27		Drug product, Delist requested	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6479496	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6503911	2019-05-27		Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6525057	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6562826	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6617328	2019-05-27		Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6620814	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6852724	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-001	6864258	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6303607	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6369062	2019-05-27		Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6479496	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6503911	2019-05-27		Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6525057	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6562826	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6617328	2019-05-27		Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6620814	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6852724	2019-05-27	U-705		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021526-002	6864258	2019-05-27	U-705		`3f01610625f2…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4367aed1-e488-b72c-d0ec-178a4e054129	Product name	9	20250624
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
ddc83a74-720a-4975-8550-c4bd979c9094	Product name	1	20221212
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61958-1003-1	EA - Each	61958-1003	e968d4ff-306a-413a-b922-afbcff0830ab	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
RANOLAZINE	ACTIVE INGREDIENT	A6IEZ5M406	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
RANOLAZINE	ACTIVE MOIETY	A6IEZ5M406	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
POLYETHYLENE GLYCOL 3350	INACTIVE INGREDIENT	G2M7P15E5P	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
WATER	INACTIVE INGREDIENT	059QF0KO0R	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [GILEAD SCIENCES, INC.]	8
RANOLAZINE	ACTIVE INGREDIENT	A6IEZ5M406	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
RANOLAZINE	ACTIVE MOIETY	A6IEZ5M406	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
POLYETHYLENE GLYCOL 3350	INACTIVE INGREDIENT	G2M7P15E5P	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	RANEXA (RANOLAZINE) TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
A6IEZ5M406	RANOLAZINE	95635-55-5	RANOLAZINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
860738	Ranexa 500 MG 12HR Extended Release Oral Tablet	PSN	e038f963-d78f-460e-a11f-46f224061505	3
616749	ranolazine 500 MG 12HR Extended Release Oral Tablet	PSN	e038f963-d78f-460e-a11f-46f224061505	3
860738	12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa]	SBD	e038f963-d78f-460e-a11f-46f224061505	3
616749	12 HR ranolazine 500 MG Extended Release Oral Tablet	SCD	e038f963-d78f-460e-a11f-46f224061505	3
860738	Ranexa 500 MG 12 HR Extended Release Oral Tablet	SY	e038f963-d78f-460e-a11f-46f224061505	3
616749	ranolazine 500 MG 12 HR Extended Release Oral Tablet	SY	e038f963-d78f-460e-a11f-46f224061505	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
61958-1003-1	61958100301	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (61958-1003-1)	2006-01-27	0000-00-00	No	No	Current
61958-1003-2	61958100302	14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (61958-1003-2)	2006-01-27	0000-00-00	No	No	Current
61958-1003-3	61958100303	14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (61958-1003-3)	2006-01-27	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Ranexa	Gilead Sciences, Inc.	2023-03-02	HUMAN PRESCRIPTION DRUG LABEL	15
Ranexa	Carilion Materials Management	2016-08-06	HUMAN PRESCRIPTION DRUG LABEL	3
Ranexa	Aphena Pharma Solutions - Tennessee, LLC	2016-07-27	HUMAN PRESCRIPTION DRUG LABEL	1